Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc > Highlight from earning call transcript
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Marathon11on Nov 04, 2019 9:51pm
148 Views
Post# 30308218

RE:Highlight from earning call transcript

RE:Highlight from earning call transcriptWell put! Other opportunities... Why has the company not mentioned their largest opportunity, Resultz in the US... Ledger sounded like Elmer Fudd when asked about it earlier this year. Resultz US agreement... why no mention?... or any other global licencing agreements?... silence. Sitting on their hands. Have they agreed to sit on their hands for a select period of time so the stock can be manipulated??? Why was the Vimovo court decision only 5 -6 months after the acquisition? was that not anticipated? Incompetence or planned to tank the stock price and send retail investors to the exits for friends? Has the Vimovo revenue actually changed since that news? Nope ... but how about the stock price? The traders can and will manipulate the stock price up and down. Are the BOD acting in the best interest of shareholders or others... fiduciary duty? Just my thoughts and opinion... I have lots of friends...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities